Recent Updates
Recently added Catalysts
SEER Positive Sentiment

Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

Key Takeaway: Seer, Inc. announced it will report its financial results for the second quarter of 2026 on August 11, 2026. The company will host a conference call at 1:30 p.m. PT, which will be available via webcast. Seer is recognized for its advancements in deep proteomics, providing significant insights in the field.

Market Sentiment Analysis

POSITIVE FACTORS

  • Seer is reporting its financial results, indicating business activity.
  • The company is actively engaging with investors through a webcast.
  • Seer continues to innovate in the field of proteomics.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~30 mo
Minimal dilution risk
Lead asset
standardized turmeric root extract
Phase 1 · Cystic Fibrosis

Full Press Release Details

REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2026 on Tuesday, August 11, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer's Proteograph Product Suite integrates proprietary engineered nanoparticles, automation instrumentation, optimized consumables, and advanced analytical software. Seer's products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.

Media Contact: Patrick Schmidt pr@seer.bio

Investor Contact: Marissa Bych investor@seer.bio

Frequently Asked Questions

When will Seer report its Q2 2026 financial results?

Seer will report its Q2 2026 financial results on August 11, 2026.

What time is the Seer conference call?

The conference call will begin at 1:30 p.m. Pacific Time.

Where can I access the Seer webcast?

The webcast will be available on the Investor section of Seer's website.

What is Seer's focus in the biopharma industry?

Seer specializes in deep, unbiased proteomics, providing advanced insights.

Last updated: Aug 3, 2026